MP41-20 DEFINING THE UTILITY OF MSK-ACCESS, A CELL-FREE TUMOR DNA ASSAY, IN PATIENTS TREATED WITH RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER

Authors

Peter A Reisz MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

9-2021

Volume

206

Issue

3

First Page

769

Last Page

769

Published In/Presented At

https://doi.org/10.1097/JU.0000000000002062.20

Disciplines

Medicine and Health Sciences

Department(s)

Department of Surgery

Document Type

Article